Azithromycin in viral infections
Azithromycin (AZM) is a synthetic macrolide antibiotic effective against a broad range of bacterial and mycobacterial infections. Due to an additional range of anti‐viral and anti‐inflammatory properties, it has been given to patients with the coronaviruses SARS‐CoV or MERS‐CoV. It is now being inve...
Autors principals: | Oliver, ME, Hinks, TSC |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Wiley
2020
|
Ítems similars
-
Azithromycin for mild-to-moderate COVID-19 - Authors' reply
per: Hinks, TSC
Publicat: (2021) -
Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
per: Lavoie, G, et al.
Publicat: (2024) -
Study of MAIT cell activation in viral infections in vivo
per: Hinks, TSC, et al.
Publicat: (2019) -
Boosting MAIT cells as immunotherapy: Context is everything
per: Hinks, TSC
Publicat: (2020) -
Azithromycin for mild-to-moderate COVID-19: author's reply
per: Hinks, TSC, et al.
Publicat: (2021)